Dianthus Therapeutics, Inc. /DE/ (DNTH) Form 8-K Material Events
Dianthus Therapeutics, Inc. /DE/ (DNTH) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DNTH
CIK: 1690585
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerMark Hanulak
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-18 | 2026-09-17 | 4 | 0001273351-26-000006 | View SEC Doc Filr Page |
| S-3ASR | 2026-09-18 | — | S-3ASR | 0001193125-26-395502 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009619 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 | 0001992260-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008950 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-19 | 4 | 0001688199-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | 4 | 0001778623-26-000009 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005203 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0000902219-26-000243 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | 4 | 0001779934-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | 4 | 0001688199-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 | 0001778623-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007911 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001974158-26-000096 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007887 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | 4 | 0001669866-26-000010 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001950047-26-007814 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001950047-26-007811 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001950047-26-007793 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0001897612-26-000577 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0001897612-26-000576 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001690585-26-000034 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001690585-26-000033 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002551 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | 4 | 0001992324-26-000008 | View SEC Doc Filr Page |